Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent.
alendronate
archaeolipids
endothelial
inflammation
Journal
Beilstein journal of nanotechnology
ISSN: 2190-4286
Titre abrégé: Beilstein J Nanotechnol
Pays: Germany
ID NLM: 101551563
Informations de publication
Date de publication:
2024
2024
Historique:
received:
16
01
2024
accepted:
16
04
2024
medline:
22
5
2024
pubmed:
22
5
2024
entrez:
22
5
2024
Statut:
epublish
Résumé
Sodium alendronate (ALN) is a very hydrosoluble and poorly permeable molecule used as an antiresorptive agent and with vascular anticalcifying capacity. Loaded into targeted nanovesicles, its anti-inflammatory activity may be amplified towards extra-osseous and noncalcified target cells, such as severely irritated vascular endothelium. Here cytotoxicity, mitochondrial membrane potential, ATP content, and membrane fluidity of human endothelial venous cells (HUVECs) were determined after endocytosis of ALN-loaded nanoarchaeosomes (nanoARC-Chol(ALN), made of polar lipids from
Identifiants
pubmed: 38774586
doi: 10.3762/bjnano.15.46
pmc: PMC11106671
doi:
Types de publication
Journal Article
Langues
eng
Pagination
517-534Informations de copyright
Copyright © 2024, Jerez et al.